The depo shot lawsuit is picking up speed in 2026 as thousands of women pursue legal claims against Pfizer. These lawsuits allege that Depo-Provera, one of the most widely used birth control injections in the world, caused meningioma brain tumors without adequate warning.
If you received Depo-Provera and were later diagnosed with a meningioma, you may have a valid legal claim. This article covers everything you need to know about the lawsuit: who qualifies, expected settlement amounts, filing deadlines, and the latest court updates.
Here's a fact that caught many people off guard. A major 2024 study in the BMJ found that long-term Depo-Provera use increased meningioma risk by up to 5.6 times. That single finding helped fuel a wave of litigation that continues to grow.
You'll find eligibility breakdowns, payout projections, and step-by-step filing instructions below. Every section is written for real people, not lawyers.
What Is the Depo Shot Lawsuit About
The depo shot lawsuit is a growing body of legal claims filed by women who developed meningioma brain tumors after receiving Depo-Provera injections. These lawsuits target Pfizer and its subsidiaries for allegedly failing to warn patients and doctors about the elevated risk of brain tumors.
Depo-Provera contains medroxyprogesterone acetate, a synthetic progestin. This hormone is injected every three months to prevent pregnancy. Millions of women in the U.S. have used it since the FDA approved it in 1992.
The core legal argument is straightforward. Plaintiffs say Pfizer knew or should have known about the brain tumor risk. They claim the company did not update its labeling or safety warnings.
| Detail | Info |
|---|---|
| Drug Name | Depo-Provera |
| Active Ingredient | Medroxyprogesterone acetate |
| Manufacturer | Pfizer (formerly Upjohn) |
| FDA Approval Year | 1992 |
| Primary Allegation | Failure to warn about meningioma risk |
| Lawsuit Type | Mass tort / product liability |
These cases are not about minor side effects like weight gain or irregular periods. They center on serious, life-altering brain tumors that often require surgery. Some women have undergone multiple craniotomies. Others suffered permanent neurological damage.
The number of filed cases continues to climb. Legal analysts estimate that by mid-2026, thousands of individual lawsuits could be consolidated into federal multidistrict litigation.
Depo Shot Brain Tumor Lawsuit Explained
The depo shot brain tumor lawsuit specifically targets the connection between prolonged Depo-Provera use and meningioma development. Meningiomas are tumors that form in the membranes surrounding the brain and spinal cord.
Most meningiomas are classified as benign. But "benign" is misleading here. These tumors can grow large enough to press against the brain. They cause seizures, vision loss, headaches, cognitive problems, and personality changes.
The scientific link between progestin exposure and meningioma growth is well-documented. Meningioma cells frequently contain progesterone receptors. When a woman receives repeated high-dose progestin injections, those receptors can trigger abnormal cell growth.
Think of it like watering a seed you didn't know was planted. The progestin doesn't create the tumor from nothing, but it gives existing cells the fuel to grow out of control.
- BMJ Study (2024): Found a 5.6x increased risk of meningioma with prolonged use
- French National Health Insurance Study: Confirmed elevated risk after one year of use
- WHO Classification: Meningiomas grade I through III, with higher grades being more aggressive
Women who received Depo-Provera for one year or longer face the highest documented risk. Many plaintiffs report that their doctors never mentioned brain tumors as a potential side effect.
The failure to warn is the legal backbone of these brain tumor claims.
The Lawsuit Against Depo Shot and Pfizer
The lawsuit against depo shot centers on Pfizer Inc., the pharmaceutical giant that manufactures and markets Depo-Provera. Pfizer acquired the drug through its merger with Upjohn, the original developer.
Plaintiffs argue that Pfizer had access to safety data stretching back decades. European regulators flagged the meningioma connection before U.S. regulators took action. France's national drug agency, ANSM, issued warnings as early as 2020.
Despite this, Pfizer did not voluntarily update the Depo-Provera label in the United States to include a meningioma warning. The lawsuits allege this amounts to a knowing failure to protect patients.
| Allegation | Details |
|---|---|
| Failure to Warn | No meningioma warning on U.S. label for decades |
| Negligence | Ignored European safety signals |
| Defective Design | Unreasonably dangerous progestin dosage |
| Fraudulent Concealment | Allegedly withheld internal safety data |
Pfizer has publicly stated that Depo-Provera's safety profile is well-established. The company has pointed to its FDA-approved labeling as evidence of compliance. But plaintiffs' attorneys counter that FDA approval does not shield a manufacturer from liability when the company possesses internal data showing undisclosed risks.
This is a common pattern in pharmaceutical litigation. Companies often argue regulatory compliance. Courts often reject that defense when evidence shows the company knew more than it disclosed.
The legal battle is expected to intensify throughout 2026.
Key Takeaway: The depo shot lawsuit accuses Pfizer of hiding brain tumor risks tied to Depo-Provera, with scientific studies showing up to a 5.6x increase in meningioma risk for long-term users.
Is There a Depo Shot Class Action Lawsuit
There is no certified depo shot class action lawsuit at this time. The legal proceedings are structured as a mass tort, not a class action. This distinction matters a lot for your potential payout.
In a class action, one lawsuit represents all plaintiffs. Everyone gets the same outcome. A mass tort is different. Each plaintiff files an individual case. Your case is evaluated on your unique medical history, treatment, and damages.
Here's why that's actually good news for claimants. Mass tort cases often result in higher individual payouts. Your settlement reflects your specific injuries, not a flat average split among thousands of people.
- Class Action: One case, one settlement, divided equally among all members
- Mass Tort: Individual cases, individual settlements based on personal damages
- MDL (Multidistrict Litigation): Cases consolidated for pretrial efficiency but remain individual
Many people search for "depo shot class action lawsuit" because the term is familiar. But mass tort structure gives each plaintiff more control and potentially more money.
The cases may be grouped into a federal MDL for pretrial proceedings. That consolidation speeds up the discovery phase and avoids conflicting rulings across different courts. But when it comes to settlement or trial, each case stands on its own.
If an MDL is formally established in 2026, a single federal judge will oversee all pretrial matters. Individual cases would then be sent back to their home courts for trial if no global settlement is reached.
Depo Provera Lawsuit Update for 2026
The depo provera lawsuit update for 2026 shows significant momentum in the litigation. The number of filed cases has grown substantially since the first wave of lawsuits hit federal courts in late 2024.
As of early 2026, attorneys across the country are actively filing new claims. The Judicial Panel on Multidistrict Litigation (JPML) has been petitioned to consolidate cases into a single MDL. A ruling on that petition is expected in the first half of 2026.
| Milestone | Expected Timeline |
|---|---|
| JPML MDL Decision | Early to mid-2026 |
| Discovery Phase | Mid-2026 through early 2027 |
| Bellwether Trial Selection | Late 2026 to early 2027 |
| First Bellwether Trials | 2027 (projected) |
| Settlement Talks | Possibly late 2027 or 2028 |
Several major plaintiff law firms have built dedicated litigation teams for these cases. Expert witnesses in neuro-oncology, pharmacology, and epidemiology are being retained on both sides.
Pfizer is expected to challenge the science aggressively during the discovery phase. The company will likely argue that meningiomas have multiple causes and that individual plaintiffs cannot prove Depo-Provera specifically caused their tumors.
Bellwether trials are the ones to watch. These are test cases selected to represent the broader litigation. Their outcomes often shape settlement negotiations. If plaintiffs win big at bellwether trials, Pfizer faces enormous pressure to settle the remaining cases.
The litigation is still in its early stages. But 2026 is the year the legal infrastructure gets built.
Depo Provera Meningioma Lawsuit Details
The depo provera meningioma lawsuit focuses on a specific injury: the development of meningioma brain tumors following repeated Depo-Provera injections. Meningiomas account for approximately 40% of all primary brain tumors in the United States.
These tumors grow from the meninges, the protective layers covering the brain. While many are slow-growing, they can cause devastating symptoms depending on their size and location.
Common symptoms reported by plaintiffs include:
- Persistent headaches that worsen over time
- Seizures with no prior history
- Vision changes, including partial blindness
- Difficulty with memory, speech, or concentration
- Weakness or numbness in the limbs
- Personality or behavioral changes
The surgical treatment for meningioma is called a craniotomy. Surgeons open the skull to remove the tumor. Some patients need radiation therapy afterward. Others face multiple surgeries when tumors recur.
One plaintiff in a pending case reported receiving Depo-Provera injections for eight years before being diagnosed with a golf-ball-sized meningioma. She underwent two surgeries and still experiences seizures.
Cases like this illustrate the human cost behind the legal filings. These are not abstract injuries. They are life-changing events that robbed women of their health, their careers, and their independence.
The lawsuit alleges Pfizer could have prevented much of this suffering by simply adding a warning to the label.
Key Takeaway: The meningioma lawsuits involve women who developed brain tumors after Depo-Provera use, with many requiring brain surgery, radiation, and ongoing medical care for recurring tumors.
Who Qualifies for the Depo Shot Lawsuit
You may qualify for the depo shot lawsuit if you received Depo-Provera injections and were later diagnosed with a meningioma brain tumor. The basic eligibility criteria center on two factors: use of the drug and development of the injury.
Most attorneys evaluating these cases look for a clear timeline. Did you use Depo-Provera for a sustained period before your diagnosis? Cases with at least one year of continuous use tend to be the strongest.
General qualification criteria include:
- Received at least four Depo-Provera injections (one year of use)
- Diagnosed with a meningioma brain tumor
- Diagnosis occurred during or after Depo-Provera use
- Can provide medical records documenting both the injections and the diagnosis
You do not need to have undergone surgery to qualify. Women who are currently monitoring a diagnosed meningioma may still have valid claims. The diagnosis itself, combined with documented Depo-Provera use, forms the basis of the claim.
| Factor | Stronger Case | Weaker Case |
|---|---|---|
| Duration of Use | 2+ years | Less than 6 months |
| Diagnosis | Confirmed meningioma via MRI/biopsy | Unconfirmed or suspected tumor |
| Medical Records | Complete injection and diagnosis records | Missing or incomplete records |
| Treatment | Surgery, radiation, or ongoing monitoring | No documented treatment |
Family members of women who died from meningioma complications after Depo-Provera use may also qualify to file wrongful death claims.
If you're unsure whether you qualify, gathering your medical records is the first step. Injection records from your doctor's office and imaging reports showing your meningioma are the two most important documents.
Depo Provera Lawsuit Eligibility Requirements
Depo provera lawsuit eligibility requires documented proof of both drug exposure and injury. Attorneys and courts will look for medical evidence connecting your Depo-Provera use to your meningioma diagnosis.
The eligibility bar is not as complicated as it might seem. You need to show three things: you took the drug, you got the tumor, and the timeline makes medical sense.
Required documentation typically includes:
- Pharmacy records or clinic records showing Depo-Provera prescriptions
- Medical records confirming meningioma diagnosis (MRI, CT scan, biopsy report)
- Treatment records (surgery notes, radiation records, follow-up visits)
- Timeline showing Depo-Provera use preceded or overlapped with tumor development
Some women worry because they used Depo-Provera years ago and may not have perfect records. Law firms handling these cases often have investigators who can help retrieve old pharmacy records, insurance claims data, and clinic files.
There are some situations that could complicate eligibility. If you have a family history of meningiomas or were exposed to significant radiation (another known risk factor), Pfizer's defense team will likely argue alternative causation.
That said, having other risk factors does not automatically disqualify you. It means your attorney needs to build a stronger case showing Depo-Provera was a substantial contributing factor.
Women of all ages have filed claims. The drug was prescribed to women as young as their teens and as old as their fifties. There is no age restriction on eligibility.
Depo Shot Lawsuit Settlement Amounts
Depo shot lawsuit settlement amounts have not been finalized because the litigation is still in its early stages. No global settlement has been reached as of 2026. But legal experts have projected potential ranges based on comparable pharmaceutical cases.
Individual settlement values will depend on several factors. The severity of your injury, the cost of your medical treatment, and the strength of your evidence all play a role.
| Injury Severity | Estimated Settlement Range |
|---|---|
| Meningioma with monitoring only | $75,000 to $200,000 |
| Meningioma requiring single surgery | $200,000 to $500,000 |
| Meningioma with multiple surgeries | $500,000 to $1,500,000 |
| Permanent disability or death | $1,000,000 to $3,000,000+ |
These are projections based on similar mass tort pharmaceutical cases. Actual numbers could be higher or lower depending on bellwether trial outcomes and Pfizer's willingness to negotiate.
For context, look at past pharmaceutical settlements. The Zantac litigation involved similar failure-to-warn claims and projected individual payouts in the six-figure range. The NuvaRing settlement in 2014 paid out approximately $100 million across roughly 3,800 claims, averaging about $26,000 per claim for less severe injuries.
The Depo-Provera cases involve brain tumors, which are far more serious than many prior pharmaceutical injury claims. That severity could push individual payouts significantly higher.
No one can guarantee a specific dollar amount at this stage. But the strength of the scientific evidence and the seriousness of the injuries suggest substantial settlement potential.
Key Takeaway: While no settlements have been finalized, projected depo shot lawsuit payouts range from $75,000 for monitored meningiomas to over $1 million for cases involving permanent disability or death.
What Is the Expected Depo Shot Lawsuit Payout
The expected depo shot lawsuit payout depends entirely on your individual circumstances. There is no flat payment amount because these cases are processed as individual mass tort claims, not a class action with equal distribution.
Your payout will be calculated based on a combination of factors. Think of it as a scoring system. The more boxes you check, the higher your potential compensation.
Factors that increase payout value:
- Longer duration of Depo-Provera use
- Larger tumor size at diagnosis
- Need for surgical intervention (craniotomy)
- Multiple surgeries or tumor recurrence
- Permanent neurological damage (vision loss, seizures, cognitive impairment)
- Lost wages and diminished earning capacity
- Ongoing medical expenses
- Pain and suffering documentation
Factors that could reduce payout value:
- Short duration of drug use
- Small, asymptomatic tumor requiring only monitoring
- Pre-existing conditions that could explain the tumor
- Incomplete medical records
A woman who used Depo-Provera for five years, developed a large meningioma, underwent two surgeries, and now experiences chronic seizures would be in the highest payout tier. A woman who used it for one year and has a small, stable meningioma under observation would likely receive a lower amount.
Payouts are not expected to begin until settlement negotiations conclude or bellwether trials produce verdicts. Realistically, most claimants should not expect checks before late 2027 or 2028 at the earliest.
Depo Provera Side Effects and Brain Tumor Risk
Depo provera side effects extend well beyond the commonly discussed issues like weight gain and irregular bleeding. The most serious alleged side effect is the development of meningioma brain tumors, which sits at the center of the current litigation.
The connection between progestin and meningioma is grounded in biology. Meningioma tumors express progesterone receptors at very high rates. Research shows that approximately 70% of meningiomas are progesterone-receptor positive. When these receptors are repeatedly activated by a synthetic progestin like medroxyprogesterone acetate, tumor growth can accelerate.
Key studies supporting the link:
- BMJ Study (March 2024): Analyzed over 108,000 women in a French nationwide cohort. Found prolonged use of injectable medroxyprogesterone acetate increased meningioma risk by 5.6 times.
- American Journal of Obstetrics and Gynecology: Earlier research flagging elevated intracranial tumor risk with long-term hormonal contraceptive use.
- WHO Monitoring Data: Multiple safety signal reports linking progestin-only contraceptives to meningioma.
| Known Side Effect | Severity | Relevance to Lawsuit |
|---|---|---|
| Weight gain | Mild | Not part of lawsuit |
| Bone density loss | Moderate | Not primary claim |
| Irregular bleeding | Mild to moderate | Not primary claim |
| Depression/mood changes | Moderate | Supporting evidence in some cases |
| Meningioma brain tumor | Severe/life-threatening | Primary basis for all claims |
The FDA has acknowledged these studies but has not yet mandated a black box warning on Depo-Provera for meningioma risk. Plaintiffs argue this regulatory gap allowed Pfizer to continue selling the drug without proper disclosure.
How to File a Depo Shot Lawsuit
Filing a depo shot lawsuit starts with gathering your medical records and contacting an attorney experienced in pharmaceutical mass tort litigation. The process is more straightforward than most people expect.
Here is the step-by-step process:
Step 1: Collect Your Medical Records
Get your Depo-Provera injection records from your doctor, clinic, or pharmacy. Request your meningioma diagnosis records, including MRI or CT scan reports and any biopsy or pathology results.
Step 2: Contact a Mass Tort Attorney
Reach out to a law firm handling Depo-Provera cases. Most offer free case evaluations. You typically pay nothing upfront. These cases are handled on a contingency fee basis, meaning the attorney gets paid only if you receive a settlement or verdict.
Step 3: Case Review and Signing
The attorney reviews your records to confirm eligibility. If your case qualifies, you sign a retainer agreement. The firm then prepares and files your complaint.
Step 4: Your Case Enters the Legal System
Once filed, your case may be transferred to the MDL (if one is established) for pretrial proceedings. Discovery begins, where both sides exchange evidence.
Step 5: Wait for Resolution
Your case will either settle during negotiations or proceed toward trial. Most mass tort cases settle before trial, but the timeline can take two to four years from filing to payout.
- You do not need to appear in court in most cases
- Your attorney handles all legal filings and communications
- There is typically no cost to you unless you win
The biggest mistake people make is waiting too long. Statutes of limitations vary by state, and the sooner you file, the stronger your position.
Key Takeaway: Filing a depo shot lawsuit involves collecting medical records, contacting a mass tort attorney for a free evaluation, and signing on for representation with no upfront cost.
Depo Shot Lawsuit Deadline You Need to Know
The depo shot lawsuit deadline varies depending on your state's statute of limitations for personal injury and product liability claims. There is no single national deadline, but time is running out for many potential claimants.
Most states set their statute of limitations at two to three years from the date you discovered (or should have discovered) the connection between Depo-Provera and your injury. This is called the "discovery rule."
| State Example | Statute of Limitations | Discovery Rule |
|---|---|---|
| California | 2 years | Yes, from date of discovery |
| Texas | 2 years | Yes |
| New York | 3 years | Yes |
| Florida | 2 years (updated 2024) | Yes |
| Illinois | 2 years | Yes |
| Pennsylvania | 2 years | Yes |
The discovery rule is important here. Many women used Depo-Provera years ago but only recently learned about the meningioma connection. If you were diagnosed with a meningioma in 2022 but didn't learn about the link to Depo-Provera until the BMJ study was published in March 2024, your statute of limitations clock may have started in 2024, not 2022.
But this argument has limits. Courts can rule differently on when you "should have known." Waiting too long creates risk.
The safest approach is to act now. If you're even considering a claim, consult an attorney before your state's deadline passes. Missing the filing window means losing your right to compensation permanently. No exceptions.
Some attorneys believe an MDL, once established, could create tolling agreements that pause the statute of limitations for pending claims. But that's not guaranteed.
Depo Provera MDL Status in 2026
The depo provera MDL status is one of the most closely watched developments in pharmaceutical litigation right now. As of 2026, a formal petition to create a multidistrict litigation has been submitted to the Judicial Panel on Multidistrict Litigation (JPML).
An MDL consolidates all federal cases before a single judge for pretrial proceedings. This includes discovery, expert witness challenges (Daubert hearings), and motion practice. The goal is efficiency. Instead of hundreds of judges handling the same issues, one judge manages them all.
What happens if the MDL is granted:
- All federal Depo-Provera meningioma cases transfer to one court
- A lead counsel team is appointed to represent all plaintiffs
- Discovery proceeds on a coordinated schedule
- Bellwether cases are selected for trial
- Settlement negotiations often begin after bellwether outcomes
What happens if the MDL is denied:
- Cases remain in their individual federal courts
- Each case proceeds independently
- The process becomes slower and more fragmented
- Settlement pressure on Pfizer decreases
| MDL Milestone | Projected Timing |
|---|---|
| JPML Hearing | First half of 2026 |
| MDL Transfer Order (if granted) | Mid-2026 |
| Case Management Conference | Late 2026 |
| Bellwether Selection | Late 2026 to early 2027 |
| First Bellwether Trial | 2027 |
Legal observers widely expect the MDL to be granted. The case volume is growing, and the factual and legal issues are common across all claims. There is strong precedent for consolidation in similar pharmaceutical cases like Zantac, Roundup, and talcum powder litigation.
The assigned judge will have enormous influence over the litigation's direction. Plaintiff attorneys are watching the venue selection closely, as some courts have reputations for being more favorable to one side.
Reasons Behind the Lawsuit for Depo Shot Users
The lawsuit for depo shot users exists because Pfizer allegedly prioritized profits over patient safety. The legal claims boil down to one core accusation: the company knew about the brain tumor risk and chose not to tell anyone.
Multiple factors support this claim:
- European regulators acted first. France issued meningioma warnings for progestin-containing medications years before any U.S. action. If European regulators saw the risk, Pfizer's own scientists likely did too.
- Scientific literature was available. Peer-reviewed studies linking progestins to meningioma were published well before the current wave of lawsuits. Pfizer had access to the same research.
- The drug label stayed unchanged. Despite mounting evidence, Depo-Provera's U.S. prescribing information did not include a meningioma warning for decades.
- Internal safety monitoring should have flagged the signal. Pharmaceutical companies are required to monitor adverse event reports. Plaintiffs allege Pfizer received reports of meningioma but did not act on them.
This isn't the first time a major pharmaceutical company has faced these kinds of accusations. Johnson & Johnson faced similar claims with its talcum powder products. Bayer dealt with comparable litigation over Roundup. The pattern is consistent: safety signals emerge, the company delays, patients suffer, lawsuits follow.
For individual women, the reasons are deeply personal. They trusted their doctor. They trusted the drug. Nobody told them a birth control shot could cause a brain tumor. That broken trust is what drives these cases forward.
Key Takeaway: The lawsuits exist because Pfizer allegedly had evidence of meningioma risk from European regulators, published studies, and adverse event reports but failed to update U.S. warnings for decades.
Depo Shot Cancer Lawsuit Claims
Depo shot cancer lawsuit claims represent a subset of the broader litigation, though technically meningiomas are classified as tumors rather than cancers in most cases. The distinction matters medically but has limited impact on the legal claims.
Most meningiomas are WHO Grade I, meaning they are slow-growing and classified as benign. However, some are Grade II (atypical) or Grade III (malignant). Grade II and III meningiomas behave more like cancers, growing aggressively and requiring intensive treatment.
| WHO Grade | Classification | Behavior | Treatment |
|---|---|---|---|
| Grade I | Benign | Slow-growing | Surgery, observation |
| Grade II | Atypical | Moderately aggressive | Surgery + radiation |
| Grade III | Malignant/Anaplastic | Aggressive, can spread | Surgery + radiation + possible chemo |
Women diagnosed with Grade II or III meningiomas after Depo-Provera use have the strongest cancer-related claims. These cases involve more extensive treatment, higher medical costs, and greater long-term damage.
Some plaintiffs have also raised concerns about other cancer risks associated with Depo-Provera, including breast cancer. A 2012 study published in the journal Cancer Research found a modest increase in breast cancer risk among recent Depo-Provera users. While breast cancer claims are less common in the current litigation wave, they could emerge as the science develops.
The term "cancer lawsuit" captures the public's attention because it conveys the seriousness of the injury. Whether the tumor is technically benign or malignant, the impact on a patient's life can be equally devastating. A "benign" tumor that requires brain surgery is anything but harmless.
Attorneys are filing these claims under product liability and failure-to-warn theories regardless of the tumor's grade. The legal standard does not require a cancer diagnosis. It requires proof of a serious injury caused by the defendant's product.
Frequently Asked Questions
How much money can I get from a depo shot lawsuit?
Settlement amounts have not been finalized, but legal experts project payouts ranging from $75,000 to over $1 million depending on injury severity.
Women who required brain surgery and suffered permanent damage are expected to receive the highest amounts.
Payments are unlikely to begin before late 2027 or 2028.
Is there a class action lawsuit for the depo shot?
There is no class action lawsuit for the depo shot at this time.
The cases are being handled as individual mass tort claims, which means each person's case is evaluated separately.
This structure typically results in higher individual payouts than class action settlements.
What is the deadline to file a depo shot lawsuit?
The deadline depends on your state's statute of limitations, which is typically two to three years from the date you discovered the link between Depo-Provera and your injury.
The discovery rule may extend your timeline if you only recently learned about the connection.
Acting quickly is critical because missing the deadline permanently bars your claim.
Does the depo shot cause brain tumors?
A major 2024 BMJ study found that long-term Depo-Provera use increased meningioma brain tumor risk by up to 5.6 times.
Meningioma tumors are progesterone-receptor positive, and the synthetic progestin in Depo-Provera can stimulate their growth.
While Pfizer disputes the claims, the scientific evidence has been strong enough to support thousands of lawsuits.
How do I know if I qualify for the depo provera lawsuit?
You likely qualify if you received Depo-Provera injections for one year or longer and were subsequently diagnosed with a meningioma brain tumor.
Medical records documenting both your injections and your diagnosis are needed to support your claim.
Contact a mass tort attorney for a free case evaluation to confirm your eligibility.
The depo shot lawsuit in 2026 represents one of the most significant pharmaceutical cases in years. The science is strong. The injury is serious. And the legal process is moving forward.
If you received Depo-Provera and developed a meningioma, now is the time to gather your records and explore your options. Statutes of limitations are ticking in every state.
Don't wait until the filing window closes. Your health and your rights deserve attention today.
